Across TCGA pan-cancer cohorts, OR11H4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR11H4’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where OR11H4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR11H4 is over-expressed in tumor.
LUSC and KIRP are the cancer types where OR11H4 tumor–normal differential expression is most reproducible.